EUVIMEDEUVIMED entdecken
Crossref

Low-grade neuroepithelial tumor with FGFR1::TACC1 fusion: a clinicopathologic analysis of seven cases

Mei Yang, Danmei Zhou, Jie Fan, Xueling Qi, Jing Feng, Qiong Li, Yin Wang, Feng Tang, Ji Xiong, Zunguo Du

Journal of Neuro-Oncology · 2026-05 · 177 (3)

DOI: 10.1007/s11060-026-05577-5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Neuro-Oncology, online erschienen am 17.04.2026. Verfasst von Mei Yang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Huashan Hospital, Fudan University, Shanghai, 200040, China. Hauptthemen laut MEDLINE: Neoplasms, Neuroepithelial, Receptor, Fibroblast Growth Factor, Type 1, Brain Neoplasms, Microtubule-Associated Proteins. Die Arbeit nennt 28 Literaturangaben. Gefördert von: Natural Science Foundation of Shanghai, Shanghai Action Plan for Science Technology and Innovation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: To characterize the clinicopathologic, radiologic, immunophenotypic, and molecular features of low-grade neuroepithelial tumor harboring FGFR1::TACC1 fusion. METHODS: Seven cases with confirmed FGFR1::TACC1 fusion were retrospectively analyzed. Clinical information, histopathological features, immunohistochemical profiles, next-generation sequencing (NGS) results and DNA methylation–based clustering analyses were reviewed. RESULTS: All patients were male, with a median age of 14 years. Tumors were predominantly located in the cerebellum. Magnetic resonance imaging revealed mainly cystic–solid lesions with hypointensity on T1-weighted imaging and relatively well-defined margins on FLAIR sequences. Histologically, all tumors exhibited oligodendroglia-like cells with round nuclei and perinuclear halos, accompanied by neurofibrillary islands and edematous stroma. Branching capillaries (6/7), calcifications (4/7), and Rosenthal fibers (3/7) were variably observed. One case demonstrated morphologic and immunophenotypic features overlapping with extraventricular neurocytoma. Immunohistochemistry demonstrated GFAP and Olig2 expression in all cases; Syn positivity was identified in four cases and focal NeuN positivity in two cases. Focal CD34 expression was found in one. The Ki-67 was below 5% in all tumors. NGS confirmed FGFR1::TACC1 fusion in every case. DNA methylation profiling assigned tumors to multiple reference classes, including low-grade glioma (LGG), dysembryoplastic neuroepithelial tumor (DNT), pilocytic astrocytoma, posterior fossa (PA PF) and anaplastic pilocytic astrocytoma (ANA PA). No significant chromosomal arm-level copy number alterations were detected. All patients underwent gross resection, with one receiving adjuvant radiotherapy. No tumor recurrence was observed during follow-up (36–60 months). CONCLUSION: Low-grade neuroepithelial tumors with FGFR1::TACC1 fusion represent a heterogeneous entity where a single recurrent gene fusion may be associated with diverse histomorphologic features and variable DNA methylation profiles.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neoplasms, NeuroepithelialReceptor, Fibroblast Growth Factor, Type 1Brain NeoplasmsMicrotubule-Associated ProteinsOncogene Proteins, FusionHumansMaleAdolescentRetrospective StudiesChildYoung AdultDNA MethylationAdultBiomarkers, TumorChild, PreschoolFetal ProteinsNuclear Proteins

Stichwörter der Autor:innen

FGFR1Low-grade neuroepithelial tumorMethylation clusteringTACC1

Substanzen

Receptor, Fibroblast Growth Factor, Type 1TACC1 protein, humanFGFR1 protein, humanMicrotubule-Associated ProteinsBiomarkers, TumorOncogene Proteins, FusionFetal ProteinsNuclear Proteins

Autor:innen und Institutionen

  • Department of Pathology, Huashan Hospital, Fudan University, Shanghai, 200040, China.
  • Department of Pathology, Sanbo Brain Hospital, Capital Medical University, Beijing, 100093, China.
  • Department of Pathology, Huashan Hospital, Fudan University, Shanghai, 200040, China. duzunguo@fudan.edu.cn.

Förderung

  • Natural Science Foundation of Shanghai
  • Shanghai Action Plan for Science Technology and Innovation

Zitieren

APA

Yang, M., Zhou, D., Fan, J., Qi, X., Feng, J., Li, Q., Wang, Y., Tang, F., Xiong, J., & Du, Z. (2026). Low-grade neuroepithelial tumor with FGFR1::TACC1 fusion: a clinicopathologic analysis of seven cases. Journal of Neuro-Oncology, 177(3). https://doi.org/10.1007/s11060-026-05577-5

Vancouver

Yang M, Zhou D, Fan J, Qi X, Feng J, Li Q, et al. Low-grade neuroepithelial tumor with FGFR1::TACC1 fusion: a clinicopathologic analysis of seven cases. Journal of Neuro-Oncology. 2026;177(3). doi:10.1007/s11060-026-05577-5

BibTeX
@article{Yang2026,
  author = {Yang, Mei and Zhou, Danmei and Fan, Jie and Qi, Xueling and Feng, Jing and Li, Qiong and Wang, Yin and Tang, Feng and Xiong, Ji and Du, Zunguo},
  title = {Low-grade neuroepithelial tumor with FGFR1::TACC1 fusion: a clinicopathologic analysis of seven cases},
  journal = {Journal of Neuro-Oncology},
  year = {2026},
  volume = {177},
  number = {3},
  doi = {10.1007/s11060-026-05577-5}
}
Kostenlos starten →